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Introduction: The development of simple clinical tools to identify children at risk of death would enable rapid and
rational implementation of lifesaving measures to reduce childhood mortality globally.
Methods: We evaluated the ability of three clinical scoring systems to predict in-hospital mortality in a prospective
observational study of Ugandan children with fever. We computed the Lambaréné Organ Dysfunction Score (LODS),
Signs of Inflammation in Children that Kill (SICK), and the Pediatric Early Death Index for Africa (PEDIA). Model
discrimination was evaluated by comparing areas under receiver operating characteristic curves (AUCs) and
calibration was assessed using the Hosmer-Lemeshow goodness-of-fit test. Sub-analyses were performed in
malaria versus non-malaria febrile illness (NMFI), and in early (≤48 hours) versus late (>48 hours) deaths.
Results: In total, 2089 children with known outcomes were included in the study (99 deaths, 4.7% mortality). All
three scoring systems yielded good discrimination (AUCs, 95% confidence interval (CI): LODS, 0.90, 0.88 to 0.91;
SICK, 0.85, 0.83 to 0.86; PEDIA, 0.90, 0.88 to 0.91). Using the Youden index to identify the best cut-offs, LODS had the
highest positive likelihood ratio (+LR, 95% CI: LODS, 6.5, 5.6 to 7.6; SICK, 4.4, 3.9 to 5.0; PEDIA, 4.4, 3.9 to 5.0), whereas
PEDIA had the lowest negative likelihood ratio (−LR, 95% CI: LODS, 0.21, 0.1 to 0.3; SICK, 0.22, 0.1 to 0.3; PEDIA, 0.16,
0.1 to 0.3), LODS and PEDIA were well calibrated (P = 0.79 and P = 0.21 respectively), and had higher AUCs than SICK
in discriminating between survivors and non-survivors in malaria (AUCs, 95% CI: LODS, 0.92, 0.90 to 0.93; SICK, 0.86,
0.84 to 0.87; PEDIA, 0.92, 0.90 to 0.93), but comparable AUCs in NMFI (AUCs, 95% CI: LODS, 0.86, 0.83 to 0.89; SICK,
0.82, 0.79 to 0.86; PEDIA, 0.87, 0.83 to 0.893). The majority of deaths in the study occurred early (n = 85, 85.9%) where
LODS and PEDIA had good discrimination.
Conclusions: All three scoring systems predicted outcome, but LODS holds the most promise as a clinical
prognostic score based on its simplicity to compute, requirement for no equipment, and good discrimination.* Correspondence: kevin.kain@uhn.ca
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Since the implementation of Millennium Development
Goal 4 to reduce childhood mortality, the number of
deaths for children under five years of age has dropped
from 11.9 million in 1990 to 6.3 million in 2013 [1,2].
Despite considerable success in reducing childhood
mortality globally, it remains concentrated in the world’s
poorest regions, with nearly half of under-five deaths in
2012 occurring in sub-Saharan Africa. Infectious diseases
are important causes of death in children with pneumonia,
malaria, measles, meningitis and HIV/AIDS accounting
for over one-quarter of all under-five deaths in 2012 [3].
In-hospital deaths often occur within the first 48 hours
of admission [4]. Implementation of simple and effective
clinical tools to rapidly identify and treat the sickest
children is urgently needed to reduce morbidity and
mortality. Clinical scores can be used to assess disease
severity in patients admitted to hospital, compare mor-
tality rates between different institutions and regions,
and evaluate the efficacy of different interventions to
improve patient outcomes. A number of clinical severity
scoring systems have been developed in pediatric popu-
lations, including PRISM (Pediatric Risk of Mortality
Score) [5], PIM (Pediatric Index of Mortality) [6], sMODS
(simplified Multi-Organ Dysfunction Score) [7], PELOD
(paediatric logistic organ dysfunction) [8], PEWS (Pediatric
Early Warning System Score) [9], bedside PEWS [10], and
PAWS (Pediatric Advanced Warning System Score) [11].
However, many of these scores rely on laboratory data that
are not available in many resource-constrained settings and
are not practical for routine assessment of disease severity.
Recently, prognostic scoring systems have been
specifically developed for pediatric populations in
low-resource settings. These scores can be easily computed
following patient assessment by front-line health care
workers, without the need for specialized equipment,
laboratory testing or onerous paperwork. Signs of
Inflammation in Children that Kill (SICK) was developed
in India as a practical triage tool based on data from 1,099
children (44 deaths) [12,13]. The Lambaréné Organ
Dysfunction Score (LODS) was developed as a simple
clinical prediction tool to identify African children
with malaria in need of referral or close monitoring
using data from 23,809 children (1,004 deaths) with
severe Plasmodium falciparum malaria [14]. Finally, a
score was developed for early death prediction in
Kenyan children admitted to hospital (presented here as
the Pediatric Early Death Index for Africa (PEDIA)) [15].
PEDIA was developed in a cohort of 8,091 children (436
deaths) admitted to hospital in Kenya and validated in a
cohort of 4,802 children [15].
In this study we prospectively evaluated the ability of
admission LODS, SICK and PEDIA to predict outcome
in an observational study of febrile children admitted tohospital in Uganda. We assessed the discrimination and
calibration of the scores and performed sub-group
analysis to compare score performance in malaria versus
non-malaria febrile illness (NMFI), and in early (≤48 hours)
versus late (>48 hours) deaths.
Methods
Ethics
Ethical approval was granted from the Uganda National
Council for Science and Technology, Makerere University
Research Ethics Committee in Uganda, and the Toronto
Academic Health Science Network. Written informed
consent was provided by the accompanying parent or
caregiver of all study participants.
Study site and participants
This prospective observational cohort study was designed
to evaluate predictors of mortality in febrile children
presenting to Jinja Regional Referral Hospital in Uganda.
The hospital serves a catchment area of three million
people encompassing 12 districts in mid-eastern Uganda.
The children’s unit has 100 beds, an average of 650
admissions per month and is manned by a clinical
team that includes five pediatricians. The estimated
entomological inoculation rate for Jinja is six infective bites
per person per year, with malaria representing the most
common admission diagnosis in the children’s unit [16].
The primary outcome for the study was all-cause
in-hospital mortality. Inclusion criteria were: age two
months to five years; parental report of fever within
the past 48 hours, or axillary temperature greater than
37.5°C; hospitalization according to the admitting
physician’s judgment; and parent/guardian consent to
blood sampling and data collection. Outcome was
assessed by daily chart review. Malaria was diagnosed
using light microscopy of Field’s stained thick peripheral
blood smear and three-band rapid diagnostic tests (RDTs)
with P. falciparum histidine rich protein 2 (HRP2) and
pan-malaria lactate dehydrogenase (pLDH) (First Response
Malaria Ag. HRP2/pLDH Combo Rapid Diagnostic Test,
Premier Medical Corporation Limited, India) [17]. Malaria
was defined as any evidence of infection (direct visualization
of parasites or detection of parasite antigen by either HRP2
or pLDH). Peripheral oxygen saturation (SpO2) was mea-
sured using the Masimo SET® Rad-57™ pulse co-oximeter
(Masimo Corporation, Irvine, CA, USA).
Clinical scores
The clinical scores were calculated according to the
original methods and are briefly described [12,14,15].
Signs of Inflammation in Children that Kill (SICK)
SICK was calculated by adding up the pre-defined
weightings for each abnormal variable in the score [12].
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score (‘Alert’, ‘Responding to Voice’, ‘Responding to Pain only’,
or ‘Unresponsive’). Abnormal ranges and weightings for
each variable were defined as: temperature >38°C or <36°C
(weight, 1.2); heart rate >160/minutes (infant, <12 months
of age) or >150/minute (child, ≥12 months of age) (weight
0.2); respiratory rate >60 (infant) or >50/minute (child)
(weight, 0.4); systolic blood pressure <65 mm Hg (infant)
or <75 (child) (weight, 1.2); SpO2 < 90% (weight, 1.4);
capillary refill time ≥3 seconds (weight, 1.2); altered
consciousness (unresponsive, responding to voice, or
responding to pain only) (weight, 2.0). Additionally,
weights were assigned based on the subject’s age (2
to <12 months, 1.0; ≥12 to <60 months, 0.3). Each
variable was summed according to the weight generating
possible scores ranging from zero to 8.6.
Lambaréné Organ Dysfunction Score (LODS)
The LOD score was calculated by assigning a value of one
for each of the following signs present in a child to develop
a score ranging from zero to three: prostration (unable to sit
unsupported or inability of infants <6 months to breastfeed);
coma (Blantyre Coma Score <3); or deep breathing.
Pediatric Early Death Index for Africa (PEDIA)
PEDIA was calculated by adding the pre-defined weightings
for each indicator present to generate a score from zero to
eight [15]. Kwashiorkor was not included on our standard-
ized case report forms and was, therefore, not included in
the final score (weight, 1.0 in the original model). The
simplified score was generated using the following indica-
tors and weights: jaundice (weight, 1.0); subcostal indrawing
(weight, 1.0); prostration ± seizure (weight, 2.0); altered
consciousness (with seizures, weight, 2.0; without seizures,
weight, 3.0); wasting (weight, 1.0).
Statistical analysis
Analyses were performed using GraphPad Prism v6,
SPSS v20, and MedCalc v13 software. Continuous
data were analyzed by the Mann–Whitney U test, and
categorical data were analyzed by the Pearson Chi-Square
or Fisher’s exact test, as appropriate. Score discrimination
was assessed using non-parametric receiver operating
characteristic (ROC) curves and comparing the areas
under the curve (AUCs) using the method of Delong et al.
[18]. Optimal cut-offs in clinical severity scores were
determined using the Youden Index, which assigns
equal weighting to model sensitivity and specificity
(J = max(sensitivity + specificity-1)). Model calibration
was assessed using the Hosmer-Lemeshow goodness-
of-fit test comparing the observed versus expected
probability of death within each risk group/decile
derived from logistic regression models with mortality as
the dependent variable and the model (SICK, LODS,PEDIA) as independent variables. The rate of missing data
was ascertained for each variable and is presented in
Additional file 1: Table S1. A sensitivity analysis was
performed to evaluate the impact of missing data on score
performance. To evaluate how scores performed under
different conditions, we performed stratified analyses
looking at the etiology of fever (malaria versus NMFI) and
time to death (early versus late).
Role of the funding source
The funders had no role in the study design; in the
collection, analysis and interpretation of data; in the writing
of the report; or in the decision to submit the paper for
publication.
Results
A total of 2,502 children were recruited between February
2012 and August 2013 in a prospective observational
cohort study to evaluate predictors of mortality among
children hospitalized with fever (Figure 1). Outcome data
were available for 2,089 children (1,990 survivors, 99
deaths) (Table 1). The all-cause mortality rate in children
with known outcome was 4.7%. Among children with
malaria, the mortality rate was 4.0% (64/1,525), whereas
the mortality in NMFI was higher at 6.7% (33/463),
P = 0.015. The mean age of children admitted to hospital
was 20 months, and 54.3% were male. The mean time to
see a medical doctor was 2.9 hours, and the mean duration
of hospitalization was 3.1 days.
Model computation
When computing the disease severity scores, we first
evaluated the association between individual variables
included in the scores and mortality (Table 1). Forest
plots were generated depicting unadjusted odds ratios
for each clinical sign included in the scores, as well as
for the scores themselves (derived from logistic regres-
sion models) (Figure 2, Additional file 1: Table S2).
Among the variables included in SICK, younger age
(<12 months versus 12 to 60 months), altered temperature
and tachycardia were not associated with fatal outcome
irrespective of the etiology of fever; in contrast, tachypnea,
hypotension, altered capillary refill, altered consciousness
and hypoxia were all associated with increased odds of
death. Coma, deep breathing and prostration in LODS
were associated with fatal outcome. In PEDIA, jaundice
and subcostal indrawing were associated with fatal
outcome, while wasting was of borderline significance
(P = 0.076). Prostration and altered consciousness were
considered in the context of whether a child had seizures.
Seizures were associated with increased odds of
death in prostration but not in children with impaired
consciousness.
Figure 1 Flow chart of children enrolled in the study. A flow chart showing the children enrolled in the study and outcome stratified by
malaria or non-malaria febrile illness (NMFI), or early (≤48 hours) versus late (>48 hours) study deaths.
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of 1.7 in survivors compared to 3.7 in non-survivors
(P <0.0001, Mann–Whitney U test), with 86.9% of
non-survivors having SICK scores above the median.
Sixty four percent of children had none of the three
signs for the LOD score, while 20% had one sign,
12% had two signs and 4% had all three signs. Among
fatalities, 93.9% of children had a LOD score >1 with
most children having a score of 2 (n = 40, 40.4%) or 3
(n = 41, 41.4%). PEDIA scores ranged from 0 (n = 1,144,
54.8%) to 8 (n = 1) with a median score of 0 in survivors
compared to 5 in non-survivors (P <0.0001, Mann–Whitney
U test). The distribution of disease severity scores for
survivors and non-survivors is shown in Figure 3.
Model discrimination and calibration
We compared the ability of SICK, LODS and PEDIA to
discriminate between survivors and non-survivors using
ROC curves. All three scores had good discriminatory
ability with AUCs of 0.85 (95% CI, 0.83 to 0.86), 0.90
(0.88 to 0.91) and 0.90 (0.88 to 0.91) for SICK, LODS
and PEDIA, respectively (Table 2, Figure 2). The AUCs
for LODS and PEDIA were significantly higher than
that for SICK (P = 0.03 and P = 0.02, respectively). We
assessed model calibration for the models using the
Hosmer-Lemeshow Goodness-of-fit test, with P <0.05
indicating a departure from perfect fit (Table 2). LODS
and PEDIA were well calibrated, whereas SICK showed
poor calibration in this population.
Sensitivity analysis: effect of predictor variables on score
performance
Complete data were available for 89.7% of children to
compute SICK, 98.8% to compute LODS and 95.2% for
PEDIA. When comparing the distribution of missingdata, all variables included in LODS and PEDIA were
missing at random, while five out of seven variables in
the SICK score were more likely to be missing in
children who died (heart rate, respiratory rate, systolic blood
pressure, temperature, SpO2) (Additional file 1: Table S1).
To evaluate the impact of missing data, we compared model
discrimination and calibration for SICK, LODS and PEDIA
when missing data were considered normal and then
considered abnormal (Table 2). LODS and PEDIA had
comparable discrimination irrespective of how missing data
were handled. When missing data were treated as abnormal
in the SICK score, the AUC improved from 0.846 (0.83 to
0.86) in the original model to 0.854 (0.84 to 0.87) in the
modified score. The modified SICK score had higher
sensitivity (86% versus 82%) but lower specificity (77%
versus 82%) than the original. The decision to treat
missing data as normal or abnormal did not affect
model calibration.
Score performance in malaria and non-malaria febrile
illness
As LODS was developed exclusively in malaria and SICK
was developed in a non-malaria setting, we wanted to
evaluate the performance of each score in both malaria
and NMFI. In addition, despite being developed in a
cohort that included malaria and NMFI, PEDIA was
developed and validated without consideration of clinical
diagnosis. We wanted to assess the performance of all
three scores in both malaria and NMFI. Of the 2,089
children with known outcome, 1,589 (76.1%) tested
positive for malaria. The AUCs for SICK, LODS and
PEDIA in discriminating between survivors and non-
survivors in malaria and NMFI are shown in Figure 2 and
Table 2. SICK and PEDIA were not well calibrated in
malaria but showed good calibration in NMFI whereas
Table 1 Demographic and clinical features
Variable Survivors (number = 1990) Non-survivors (number = 99) P-value
Demographic and anthropometric characteristics
Age — months 17.0 (9.0-26.5) 15.0 (9.0-25.0) 0.296
Age <12 months— number (%) 609 (30.7) 35 (35.4) 0.326
Male — number (%) 1079 (54.8) 55 (56.1) 0.797
Mid-upper-arm circumference — mm 140 (130–150) 130 (120–141) <0.0001
Weight-for-age z < −3SD — number (%) 180 (9.3) 14 (14.7) 0.076
Quality of care measures
Time to see medical doctor— hours 2.7 (1.0-4.3) 1.0 (0.2-2.8) <0.0001
Examination findings at admission
Axillary temperature—°C 38.0 (37.0-38.8) 37.4 (36.6-38.1) <0.0001
Temperature >38°C— number (%) 891 (45.4) 26 (27.4) 0.001
Temperature <36°C — number (%) 70 (3.6) 11 (11.6) <0.0001
Heart rate— beats/minute 162 (146–176) 163 (145–182) 0.839
Tachycardia— number (%) 1271 (64.4) 58 (63.0) 0.788
Respiratory rate— breaths/minute 42 (36–56) 60 (44–68) <0.0001
Tachypnea— number (%) 490 (25.5) 50 (54.3) <0.0001
Deep breathing— number (%) 434 (21.8) 77 (77.8) <0.0001
Subcostal retractions— number (%) 353 (17.8) 66 (66.7) <0.0001
Prostration— number (%) 440 (22.2) 85 (85.9) <0.0001
Systolic blood pressure— mmHg 100 (100–110) 95 (90–103) <0.0001
Hypotensive— number (%) 21 (1.1) 10 (12.3) <0.0001
Capillary refill time ≥3 seconds — number (%) 86 (4.5) 20 (20.4) <0.0001
Convulsions— number (%) 350 (17.6) 33 (33.3) <0.0001
Altered consciousness— number (%) 282 (14.2) 76 (76.8) <0.0001
Coma (BCS < 3) — number (%) 76 (3.9) 53 (53.5) <0.0001
Jaundice— number (%) 188 (9.5) 25 (25.3) <0.0001
Laboratory test results at admission
Oxygen saturation 98.0 (96.0-99.0) 95.0 (88.0-99.0) <0.0001
Oxygen saturation <90% — number (%) 62 (3.1) 25 (27.5) <0.0001
Positive for malaria parasitemia — number (%) 1125 (63.0) 27 (40.3) <0.0001
RDT Results — number (%)
RDT negative 494 (25.6) 34 (35.8) 0.027
RDT pLDH positive 22 (1.1) 0 (0) 0.622
RDT HRP2 positive 237 (12.3) 19 (20.0) 0.037
RDT pLDH/HRP2 positive 1176 (61.0) 42 (44.2) 0.001
Glucose 6.9 (5.9-8.3) 5.4 (2.9-9.0) <0.0001
Lactate 2.6 (1.9-4.6) 8.2 (2.9-16.9) <0.0001
Hemoglobin 4.8 (3.4-7.0) 4.0 (2.4-6.7) 0.012
Positive for HIV antibody— number /total number (%) 39/931 (4.2) 6/37 (14.0) 0.003
Duration of follow up — days 3 (2–4) 1 (0–1) <0.0001
Data presented as median (IQR). Tachycardia (heart rate >160/minute (infant, <12 months of age) or >150/minute (child, ≥12 months of age)); tachypnea
(respiratory rate >60 (infant) or >50/minute (child)); hypotension (systolic blood pressure <65 mm Hg (infant) or <75 (child)). Prostration was defined as the
inability to breastfeed or sit unsupported according to age. Altered Consciousness was defined using AVPU where anything except ‘alert’ constituted altered
consciousness. BCS, Blantyre Coma Score; HRP2, P. falciparum histidine rich protein 2; pLDH, pan-malaria lactate dehydrogenase; RDT, rapid diagnostic test; SD,
standard deviation.
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Figure 2 Performance of SICK, LODS and PEDIA in discriminating between survivors and non-survivors. Forest plots showing unadjusted
odds ratios (95% CI) for the individual signs included in SICK, LODS, and PEDIA as well as the odds ratios of the clinical scores themselves
(derived from logistic regression models) with mortality as the dependent variable in all children (A), children with malaria (B), and children with
non-malaria febrile illness (NMFI, C). The associated receiver operating characteristic curves for A, B and C are shown in D, E and F. CI, confidence
interval; LODS, Lambaréné Organ Dysfunction Score; PEDIA, Pediatric Early Death Index for Africa; SICK, Signs of Inflammation in Children that Kill.
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Using a more specific definition of malaria (positive by
three band RDT) [17], we obtained similar results.
Performance of scores in predicting early or late death in
hospital
Finally, we wanted to compare the scores in early and
late mortality in our cohort. We plotted Kaplan-Meier
survival curves with the clinical scores stratified according
to their respective Youden indices. All scores were signifi-
cantly associated with death (log-rank test, P <0.0001)
(Figure 4), with the majority of deaths (n = 85, 85.9%)
occurring in the first 48 hours of hospitalization
(early deaths). SICK, LODS and PEDIA all had higher
AUCs in early versus late deaths, but only LODS
reached statistical significance (P = 0.036). LODS and
PEDIA were better than SICK at discriminating between
survivors and early deaths (P <0.05), but there were
no differences between any of the AUCs for the clinical
scores and late deaths (Table 2, Figure 4).Discussion
Clinical scoring systems are used in intensive care to
compare performance between units and assess mortality
in different patient groups. A similar system would be
useful in resource-constrained settings where there is
considerable heterogeneity in the quality of medical care.
Clinical scores could be used to prioritize resources (at an
individual patient level (that is, triage) and nationally/
regionally), track changes in hospital performance
over time, and monitor changes in disease patterns,
in order to facilitate early identification of outbreaks.
In this study, we validated SICK, LODS and PEDIA as
prognostic scores for in-hospital mortality in a regional
referral hospital in eastern Uganda. While all three scores
were able to discriminate between survivors and non-
survivors, LODS and PEDIA showed better discrimination
and calibration in both malaria and NMFI. Of the three
scores, LODS is the easiest to compute with only three
variables compared to seven variables in SICK and eight
variables in PEDIA, and had less missing data. As LODS
Figure 3 The distribution of disease severity scores for SICK, LODS
and PEDIA by mortality. Histograms showing the distribution of
disease severity scores for SICK (A), LODS (B), and PEDIA (C) as a
percentage of survivors (left panel, in black) or non-survivors (right panel,
in red). LODS, Lambaréné Organ Dysfunction Score; PEDIA, Pediatric Early
Death Index for Africa; SICK, Signs of Inflammation in Children that Kill.
Conroy et al. Critical Care  (2015) 19:47 Page 7 of 11had good discrimination and calibration, does not require
equipment or specialized knowledge to generate, and is the
most parsimonious, we believe it holds the most promise
as a practical, ‘real world’ prognostic scoring system.
LODS was developed using the Severe Malaria in African
Children (SMAC) network that collected data from six
research sites (five countries) across Africa, including only
children with laboratory-confirmed severe malaria [19].
Although the study validated the prognostic ability of
LODS between disparate patient and parasite populations,
and within different health care systems, it was not evalu-
ated in NMFI. In this study, we present the first evaluation
of LODS in the context of NMFI and show that each LODS
sign (coma, prostration, deep breathing) was associated
with a fatal outcome, irrespective of the etiology of fever.
The performance of LODS declined significantly when
trying to predict later deaths, which is consistent with
recent SMAC reports showing considerable variability in
model performance in predicting later deaths [20].
Although the predictors of early, intermediate and late
death varied in subsequent analyses from the SMAC
network, deep breathing, prostration and coma were
significantly associated with intermediate and late deaths
when data from all sites were analyzed together [20].
Differences in mortality kinetics and predictors of late
mortality between sites may reflect regional differences in
disease and quality of care. In our population, LODS had
better sensitivity than the original cohort (94% versus
85%, LODS >0) and comparable specificity (98% versus
98%, LODS <3). Overall, LODS had good discrimination
and calibration in malaria and NMFI, suggesting it may
have widespread utility.
SICK was developed as a childhood triage score at a
single tertiary care hospital in New Delhi [12,13]. The
variables included in SICK were defined a priori based
on physical manifestations of the systemic inflammatory
response syndrome with weightings determined using
multiple logistic regression analyses. In our study, not all
variables included in SICK were associated with fatal
outcome, suggesting a more parsimonious model could
be developed. These findings are consistent with the original
model where two variables (heart rate and respiratory rate)
did not differ between surviving and non-surviving children,
but were still included in the final model. The optimal
cut-off in our study was >2.4 and was fairly consistent in
sub-analyses, and similar to the cut-off derived from the
development cohort (>2.5). Age was not associated with
increased odds of death in our study; however, we only
included children over 2 months of age. The neonatal
period (first four weeks of life) carries one of the highest
risks of death and accounts for over 40% of under-five
deaths [21]. Had we included children of all ages in our
cohort, age would likely have been an important predictor
of death, as it was in the SICK development cohort.














SICK 0.846, 0.83-0.86 P = 0.032 (S v. L)* 0.6328, >2.4 81.8, 72.8-88.9 81.5, 79.7-83.1 χ2 = 21.11, df = 8, P = 0.007
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PEDIA 0.896, 0.88-0.91 P = 0.016 (P v. S)* 0.6727, >2 86.9, 78.6-97.1 80.4, 78.6-82.1 χ2 = 4.45, df = 3, P = 0.217
Modified Score
Performanceb
SICK 0.854, 0.84-0.87 P = 0.059 (S v. L) 0.6269, >2.4 85.9, 77.4-92.0 76.8, 74.9-78.7 χ2 = 20.42, df = 8, P = 0.009
LODS 0.897, 0.88-0.91 P = 0.801 (L v. P) 0.6915, >1 81.8, 72.8-88.9 87.3, 85.8-88.8 χ2 = 0.066, df = 1, P = 0.797
PEDIA 0.894, 0.88-0.91 P = 0.041 (P v. S)* 0.6703, >3 86.9, 78.6-92.8 78.4, 76.5-80.2 χ2 = 3.60, df = 4, P = 0.462
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LODS 0.919, 0.90-0.93 P = 0.964 (L v. P) 0.7282, >1 85.9, 75.0-93.4 86.9, 85.1-88.5 χ2 = 0.59, df = 1, P = 0.447
PEDIA 0.918, 0.90-0.93 P = 0.018 (P v. S)* 0.7186, >2 92.2, 82.7-97.4 79.7, 77.6-81.7 χ2 = 8.14, df = 3, P = 0.043
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LODS 0.862, 0.83-0.89 P = 0.859 (L v. P) 0.6517, >1 75.8, 57.7-88.9 89.4, 86.3-92.1 χ2 = 1.37, df = 1, P = 0.242
PEDIA 0.865, 0.83-0.89 P = 0.234 (P v. S) 0.6173, >2 78.8, 61.1-91.0 82.9, 79.2-86.3 χ2 = 0.34, df = 3, P = 0.952
Early Deathe
SICK 0.853, 0.84-0.87 P = 0.009 (S v. L)* 0.6499, >2.4 83.5, 73.9-90.7 81.5, 79.7-83.1 χ2 = 15.66, df = 8, P = 0.049
LODS 0.919, 0.91-0.93 P = 0.396 (L v. P) 0.7450, >1 87.1, 78.0-93.4 87.4, 85.9-88.9 χ2 = 0.33, df = 1, P = 0.565
PEDIA 0.910, 0.90-0.92 P = 0.012 (P v. S)* 0.6981, >2 89.4, 80.8-95.0 80.4, 78.6-82.1 χ2 = 5.83, df = 3, P = 0.120
Late Deathf
SICK 0.803, 0.79-0.82 P = 0.646 (S v. L) 0.5943, >2.2 71.4, 41.9-91.6 81.5, 79.7-83.1 χ2 = 9.88, df = 8, P = 0.273
LODS 0.769, 0.75-0.79 P = 0.243 (L v. P) 0.4546, >0 50.0, 23.0-77.0 87.4, 85.9-88.9 χ2 = 0.34, df = 1, P = 0.560
PEDIA 0.815, 0.80-0.83 P = 0.833 (P v. S) 0.5942, >3 71.4, 41.9-91.6 88.0, 86.5-89.4 χ2 = 0.061, df = 3, P = 0.996
Total data missing: LODS, 1.2%; SICK, 10.3%; PEDIA, 4.8%), default models consider missing data normal. aSensitivity and specificity calculated based on the
following cut-offs (LODS, >1; SICK, >2.4; PEDIA, >2); bmissing data considered abnormal in score calculation (see Additional file 1: Table S1 for description of
missing data by variable); cmalaria positive: positive by RDT (pLDH or HRP2) or microscopy (n = 1,589, 64 deaths; prevalence, 4.03%); dmalaria negative: negative
by RDT (pLDH and HRP2) and microscopy (n = 496, 33 deaths; prevalence, 6.65%); en = 2,075 (1,990 survivors and 85 deaths); fn = 2,004 (1,990 survivors and 14
deaths).*Compare AUCs (SICK, S; LODS, L; PEDIA, P) by method of Delong et al. AUC, area under the curve; CI, confidence interval; LODS, Lambaréné Organ
Dysfunction Score; PEDIA, Pediatric Early Death Index for Africa; SICK, Signs of Inflammation in Children that Kill.
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be treated as normal; however, in the context of our
cohort we found better model discrimination if we
considered missing data as abnormal since a number
of variables were not missing at random. Despite
these limitations, the discrimination of the modified SICK
score was still less than LODS and PEDIA, suggesting that
additional modifications to the SICK would be required
before SICK should be considered as a practical scoring
system in resource-constrained settings.
PEDIA is the only scoring system that was developed
in Africa in children with both malaria and non-malaria
illness [15]. In the original cohort used to develop the
prognostic score, 56% of children admitted to hospital
were positive for malaria. Thus, the score was developed
in a large cohort of children with fever of mixed etiology.
The original publication focused on developing prognosticmodels for immediate, early and late deaths. In this study,
we elected to evaluate the early death score rather than
the immediate score because it does not require any
laboratory testing, whereas the immediate death score
required assessment of anemia. PEDIA was comparable to
LODS in predicting mortality among all children, children
with malaria, NMFI, and those who died early (<48 hours)
versus late. Generally, model calibration was also good.
However, PEDIA is more complex than LODS without
offering additional predictive/prognostic value, and does
not provide additional clinical information that could be
used to direct interventions (for example, fluids or oxygen).
To avoid subjective bias and explore consistency in
score cut-offs under different conditions, we used a statis-
tical method to define the optimal score cut-off for each
analysis. We elected to use the Youden index, which gives
equal weight to sensitivity and specificity. However, alternate
Figure 4 Survival analysis and evaluation of SICK, LODS and PEDIA in predicting early versus late deaths in the first week of hospitalization.
Kaplan-Meier survival curves for each clinical score stratified according to the Youden index for SICK (A), LODS (B) and PEDIA (C). Receiver operating
characteristic curves for SICK (D), LODS (E), and PEDIA (F) in discriminating between survivors and early (<48 hours) and late deaths (≥48 hours). LODS,
Lambaréné Organ Dysfunction Score; PEDIA, Pediatric Early Death Index for Africa; SICK, Signs of Inflammation in Children that Kill.
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sensitivity or specificity. In the case of patient triage,
increased sensitivity would be desirable. While the Youden
index indicated a LOD score >1 had the best overall score
performance in our cohort, selection of ≥1 as a cut-off
would increase the sensitivity of the score from 81.8% to
93.9%. Likewise, the thresholds for SICK and PEDIA could
be changed to reflect the desired sensitivity or specificity of
the score. This will be an important consideration for future
studies when assessing the score performance in different
populations and disease conditions.
A limitation of this study was the inability to deter-
mine outcomes for all children, as approximately 15%
of patients were lost to follow up. The reasons for
the high rate of abscondment in the unit are unknown,
but consistent with ongoing surveillance studies in the
hospital. Clinically, the children who absconded were
more likely to receive a blood transfusion (42.3%)
than children who were discharged (33.7%) but less
likely to receive anti-malarial treatment (quinine or
artemisinin-based therapy). There were no differences
in clinical diagnoses (malaria, pneumonia, sepsis andmeningitis), pre-treatments or treatments (IV fluids,
glucose, antibiotics) in hospital between children who
were discharged and absconded. The absconders had
higher LOD scores than survivors but lower LOD
scores than non-survivors. In order to reliably assess
patient outcomes in resource-constrained settings, it
will be important to understand why patients abscond
(for example, quality of care, direct/indirect costs, social
reasons). Rates of missing data increased with increasing
score complexity reaching 10.3% in the SICK score. While
all variables in LODS and PEDIA were missing at random,
several of the variables in SICK were more likely to be
missing in children who died. When we evaluated which
variables were more likely to be missing (Additional file 1:
Table S1), it appears that variables requiring equipment
(blood pressure, oxygen saturation, temperature) or direct
assessment (heart rate, respiratory rate) had higher rates
of missingness. These findings may reflect the limited
resources of the site (in terms of both equipment and
personnel), as well as the severity of illness, where
documentation of vital signs was not prioritized in
situations of critical illness.
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consistent with the mortality rates observed in the cohorts
used to develop the LOD score (n = 23,890 children, 4.2%
mortality) and PEDIA score (n = 8,091, 5.1% mortality). The
sites used to develop these scores represent heterogeneous
sites across Africa where malaria transmission intensity and
the etiology of disease vary.
Conclusions
This study is the first to compare clinical scores in a
pediatric population in Africa including both malaria and
NMFI. We demonstrated that LODS has good discrimin-
ation and calibration in NMFI, and evaluated SICK in a new
population and disease context. Furthermore, we were able
to validate PEDIA in a new population and demonstrate
that it has good discrimination and calibration in febrile
illnesses of different origin, and in early and late deaths.
Overall, our data indicate that LODS is the most appropri-
ate clinical prognostic score for resource-constrained set-
tings based on its simplicity to compute, non-requirement
for equipment, good discrimination and calibration, and
suitability for implementation in both community and
health care-based settings. Future studies should evaluate
LODS in different malaria transmission settings and
evaluate whether it can be integrated with readily
available point-of-care test data (for example, hypoxemia)
or host biomarkers of disease severity (for example, Ang-2)
to improve risk prediction and/or guide therapeutics.
Key messages
 New, simple and standardized clinical tools to
objectively assess children at increased risk of death
in resource constrained settings are urgently needed.
 Implementation of lifesaving measures to children at
highest risk of adverse clinical outcomes in resource
constrained settings can reduce child mortality.
 Of three clinical scoring systems developed to
predict in-hospital mortality in developing world
settings, the Lambaréné Organ Dysfunction Score
shows the most promise as a simple, easy to
compute score that predicts death in both malaria
and non-malaria febrile illness.
 Implementation of disease severity scores in
community and hospital-based settings could be an
important tool to monitor progress in reducing child
mortality and in evaluating new therapeutics.Additional file
Additional file 1: Table S1. Evaluation of missing data used in analysis
in survivors and non-survivors. Table S2. Unadjusted odds ratios for fatal
outcome based on clinical severity scores and individual variables.Abbreviations
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